Release Date: 20/11/17 15:22 Summary: Change in substantial holding for BPG Price Sensitive: No Download Document 217.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%